CLINICAL_TRIALS
trial_result
· 2009-07-31
Clinical Trial Update: Single-Dose Study Of PF-04603629 In Type 2 Diabetic Subjects [Phase 1]
Summary
A single-dose Phase 1 study of PF-04603629 in adults with type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED